← Back to signals
REGN
STRONG BUYRegeneron Pharmaceuticals Inc.
Health Care
0.65
PEGY ratio
Rank #244
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 27.2% annually over 5 years. Pays a 0.5% dividend yield.
REGN is trading at 18.1x earnings against 27.2% growth + 0.5% yield, giving a PEGY of 0.65. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-04-24
Valuation
18.1x
P/E Ratio
Growth
27.2%
5yr EPS
Income
0.5%
Div Yield
PEGY Components
PEGY Score0.65
Denominator27.7%
EPS (TTM)$41.49
Market Data
Price$751.57
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
0.68→0.65(-0.02)
Rank
#186→#244(58 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only